FRAMINGHAM, Mass., Oct. 03, 2022 (GLOBE NEWSWIRE) — Definitive Healthcare Corp. (Nasdaq: DH), an business chief in healthcare industrial intelligence, right this moment introduced two changes to its Board of Directors. On September 30, 2022, Sastry Chilukuri, who presently serves as co-chief govt officer of Medidata, a Dassault Systèmes firm, joined the Board of Directors and the audit committee of the Board, whereas Randy Winn, managing director of 22C Capital, stepped down from the Board of Directors.
“We are thrilled to welcome Sastry Chilukuri to the Definitive Healthcare Board of Directors,” mentioned Robert Musslewhite, CEO of Definitive Healthcare. “Sastry brings a wealth of knowledge and experience in the pharmaceutical, biotech, and medical device industries. Sastry will be a valuable resource for our entire leadership team as we continue to expand our presence in the life sciences industry.”
Chilukuri was named co-CEO of Medidata in 2021. Chilukuri can be the Founder & President of Acorn AI, Medidata’s Data Science business. Chilukuri brings greater than 22 years of experience in healthcare know-how. Before becoming a member of Medidata, Chilukuri was a accomplice at McKinsey & Company, the place he labored for 12 years advising biopharma, medical system, know-how, personal fairness, and public sector purchasers world wide. Prior to that, he labored for GE Healthcare in software program engineering, product improvement, and operations. His views have been extensively disseminated, together with conferences, media, and quite a few publications on McKinsey Insights.
Chilukuri holds a Master of Business Administration from the Kellogg School of Management at Northwestern University, a Master of Science from The Ohio State University, and a Bachelor of Technology (B. Tech) from the Indian Institute of Technology (BHU) in Varanasi, India.
“I’m excited to join the Definitive Healthcare Board of Directors,” mentioned Chilukuri. “The market for healthcare commercial intelligence is large and continuing to grow. Definitive Healthcare’s innovative SaaS platform, combined with their game-changing analytics for the life sciences industries, has them perfectly positioned to be an industry leader in this important market. I look forward to bringing my decades of experience in life sciences to the team.”
Winn had served on the Definitive Healthcare Board of Directors since 2019.
“Randy has been a great partner to me and the Definitive Healthcare leadership team during his three years on the board,” mentioned Jason Krantz, Founder and Executive Chairman of Definitive Healthcare. “Randy has not only been instrumental in helping Definitive Healthcare grow to the more than 3,000 customers that we have today, but also provided insightful guidance throughout our IPO process last year. On behalf of the entire Definitive Healthcare family, I want to thank him for his service.”
About Definitive Healthcare
At Definitive Healthcare, our ardour is to remodel information, analytics and experience into healthcare industrial intelligence. We assist purchasers uncover the best markets, alternatives and other people, to allow them to form tomorrow’s healthcare business. Our SaaS platform creates new paths to industrial success within the healthcare market, so corporations can determine the place to go subsequent. Learn extra at definitivehc.com.
Forward-Looking Statements
This press launch consists of forward-looking statements, that are supplied beneath the “safe harbor” safety of the Private Securities Litigation Reform Act of 1995. Forward-looking statements embrace all statements that don’t relate solely to historic or present info, and might typically be recognized by phrases or phrases written sooner or later tense and/or preceded by phrases equivalent to “likely,” “should,” “may,” “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” or related phrases or variations thereof, or the detrimental thereof, references to future intervals, or by the inclusion of forecasts or projections, however these phrases are usually not the unique means of figuring out such statements. Examples of forward-looking statements embrace, however are usually not restricted to, statements we make relating to our outlook, continued development, and associated plans, targets and targets.
Forward-looking statements on this press launch are based mostly on our present expectations and assumptions relating to our business, the economy and different future circumstances. Because forward-looking statements relate to the long run, by their nature, they’re topic to inherent uncertainties, dangers and changes in circumstances which might be troublesome to predict. As a consequence, our precise outcomes could differ materially from these contemplated by the forward-looking statements. Important elements that would trigger precise outcomes to differ materially from these within the forward-looking statements embrace the next: an outbreak of illness, world or localized well being pandemic or epidemic, or the concern of such an occasion (such because the COVID-19 world pandemic), together with the worldwide financial uncertainty and measures taken in response; the short- and long-term results of the COVID-19 world pandemic, together with the tempo of restoration or any future resurgence; the continuing hostility between Russia and Ukraine and the associated geopolitical rigidity and affect on macroeconomic circumstances; the affect of inflation and rising rates of interest; our lack of ability to generate considerably all of our income and money flows from gross sales of subscriptions to our platform and any decline in demand for our platform and the info we provide; the competitiveness of the market wherein we function and our capability to compete successfully; the failure to keep and enhance our platform, or develop new modules or insights for healthcare industrial intelligence; the lack to receive and keep correct, complete or dependable information, which may end in decreased demand for our platform; the danger that our latest development charges will not be indicative of our future development; the lack to obtain or maintain profitability sooner or later in contrast to historic ranges as we enhance investments in our business; the loss of our entry to our information suppliers; the failure to reply to advances in healthcare industrial intelligence; an lack of ability to appeal to new prospects and develop subscriptions of present prospects; the danger of cyber-attacks and safety vulnerabilities; litigation, investigations or different authorized, governmental or regulatory actions; and the likelihood that our safety measures are breached or unauthorized entry to information is in any other case obtained.
Additional elements or occasions that would trigger our precise efficiency to differ from these forward-looking statements could emerge from time to time, and it isn’t doable for us to predict all of them. Should a number of of these dangers or uncertainties materialize, or ought to any of our assumptions show incorrect, our precise monetary situation, outcomes of operations, future efficiency and business could differ in materials respects from the efficiency projected in these forward-looking statements.
For further dialogue of elements that would affect our operational and monetary outcomes, refer to our Annual Report on Form 10-Okay for the fiscal yr ended December 31, 2021, as up to date by our Quarterly Reports on Form 10-Q, Current Reports on Form 8-Okay and different subsequent SEC filings, that are or will likely be out there on the Investor Relations web page of our web site at ir.definitivehc.com and on the SEC web site at www.sec.gov.
All data on this press launch speaks solely as of the date on which it’s made. We undertake no obligation to publicly replace this data, whether or not in consequence of new data, future developments or in any other case, besides as could also be required by legislation.
Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
[email protected]
646-277-1251
Media Contacts:
Danielle Johns
[email protected]
Highwire PR
[email protected]
